Sg Americas Securities, LLC Gilead Sciences, Inc. Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

A detailed history of Sg Americas Securities, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 87,259 shares of GILD stock, worth $7.73 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

87,259

Previous 816,047 89.31%

Holding current value

$7.73 Million

Previous $56 Million 86.93%

% of portfolio

0.03%

Previous 0.33%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	SELL	$66.59 - $83.99 $48.5 Million - $61.2 Million	-728,788 Reduced 89.31%	87,259 $7.32 Million
Q2 2024 Jul 12, 2024	BUY	$63.15 - $72.88 $41.7 Million - $48.2 Million	661,055 Added 426.51%	816,047 $56 Million
Q1 2024 May 06, 2024	BUY	$71.58 - $87.29 $3.76 Million - $4.58 Million	52,494 Added 51.21%	154,992 $11.4 Million
Q4 2023 Jan 12, 2024	BUY	$73.27 - $83.09 $2.43 Million - $2.75 Million	33,108 Added 47.71%	102,498 $8.3 Million
Q3 2023 Oct 13, 2023	SELL	$73.94 - $80.67 $3.76 Million - $4.1 Million	-50,865 Reduced 42.3%	69,390 $5.2 Million
Q2 2023 Jul 10, 2023	BUY	$76.01 - $86.7 $4.28 Million - $4.88 Million	56,255 Added 87.9%	120,255 $9.27 Million
Q1 2023 Apr 28, 2023	SELL	$77.31 - $88.08 $12.4 Million - $14.2 Million	-160,650 Reduced 71.51%	64,000 $5.31 Million
Q4 2022 Feb 02, 2023	BUY	$62.32 - $89.47 $9.25 Million - $13.3 Million	148,448 Added 194.81%	224,650 $19.3 Million
Q3 2022 Oct 31, 2022	SELL	$59.54 - $68.01 $1.37 Million - $1.57 Million	-23,045 Reduced 23.22%	76,202 $4.7 Million
Q2 2022 Jul 29, 2022	SELL	$57.72 - $65.01 $1.47 Million - $1.66 Million	-25,505 Reduced 20.44%	99,247 $6.13 Million
Q1 2022 Apr 29, 2022	BUY	$57.92 - $72.58 $1.17 Million - $1.46 Million	20,128 Added 19.24%	124,752 $7.42 Million
Q4 2021 Feb 07, 2022	BUY	$64.88 - $73.64 $2.67 Million - $3.03 Million	41,155 Added 64.84%	104,624 $7.6 Million
Q3 2021 Nov 01, 2021	SELL	$67.69 - $73.03 $8.46 Million - $9.13 Million	-125,041 Reduced 66.33%	63,469 $4.43 Million
Q2 2021 Aug 12, 2021	SELL	$63.47 - $69.35 $35.6 Million - $38.9 Million	-560,713 Reduced 74.84%	188,510 $13 Million
Q1 2021 May 13, 2021	BUY	$60.0 - $68.46 $14.8 Million - $16.8 Million	245,868 Added 48.85%	749,223 $48.4 Million
Q4 2020 Feb 04, 2021	BUY	$56.65 - $64.55 $17.7 Million - $20.2 Million	312,965 Added 164.38%	503,355 $29.3 Million
Q3 2020 Nov 09, 2020	BUY	$62.1 - $78.08 $4.41 Million - $5.55 Million	71,049 Added 59.53%	190,390 $12 Million
Q2 2020 Jul 20, 2020	SELL	$72.34 - $84.0 $2.63 Million - $3.05 Million	-36,317 Reduced 23.33%	119,341 $9.18 Million
Q1 2020 Apr 30, 2020	SELL	$62.63 - $80.22 $3.79 Million - $4.85 Million	-60,451 Reduced 27.97%	155,658 $11.6 Million
Q4 2019 Jan 28, 2020	SELL	$61.62 - $67.78 $10.1 Million - $11.1 Million	-163,561 Reduced 43.08%	216,109 $14 Million
Q3 2019 Nov 04, 2019	SELL	$62.51 - $69.0 $8.62 Million - $9.52 Million	-137,916 Reduced 26.65%	379,670 $24.1 Million
Q2 2019 Jul 29, 2019	BUY	$61.87 - $69.38 $30.1 Million - $33.7 Million	486,125 Added 1545.17%	517,586 $35 Million
Q1 2019 Apr 29, 2019	SELL	$62.53 - $70.05 $27.8 Million - $31.1 Million	-443,855 Reduced 93.38%	31,461 $2.05 Million
Q4 2018 Feb 01, 2019	SELL	$60.54 - $79.0 $41.9 Million - $54.7 Million	-692,233 Reduced 59.29%	475,316 $29.7 Million
Q3 2018 Nov 06, 2018	BUY	$71.28 - $78.92 $40.2 Million - $44.5 Million	563,523 Added 93.29%	1,167,549 $90.1 Million
Q2 2018 Aug 07, 2018	BUY	$64.88 - $75.68 $19.2 Million - $22.4 Million	295,811 Added 95.98%	604,026 $42.8 Million
Q1 2018 May 03, 2018	BUY	$72.84 - $88.8 $12.2 Million - $14.9 Million	167,359 Added 118.82%	308,215 $23.2 Million
Q4 2017 Jan 24, 2018	BUY	$71.15 - $83.52 $6.57 Million - $7.71 Million	92,283 Added 189.99%	140,856 $10.1 Million
Q3 2017 Nov 07, 2017	BUY	$72.11 - $85.47 $3.5 Million - $4.15 Million	48,573	48,573 $3.94 Million

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Gilead Sciences, Inc. Transaction History